{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:17:04Z","timestamp":1790983024959,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1124\/jpet.111.179200","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T04:56:20Z","timestamp":1308977780000},"page":"1013-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Luteolin, a Novel Natural Inhibitor of Tumor Progression Locus 2 Serine\/Threonine Kinase, Inhibits Tumor Necrosis Factor-\u03b1-Induced Cyclooxygenase-2 Expression in JB6 Mouse Epidermis Cells"],"prefix":"10.1016","volume":"338","author":[{"given":"Jong-Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Eun","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Joo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Keun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Seok","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyong Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.179200_bib1","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bcp.2006.06.029","article-title":"Inflammation and cancer: how hot is the link?","volume":"72","author":"Aggarwal","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.179200_bib2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0006-2952(97)82453-7","article-title":"Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition","volume":"53","author":"Agullo","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.179200_bib3","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/sj.onc.1207317","article-title":"Expression of both TNF-\u03b1 receptor subtypes is essential for optimal skin tumour development","volume":"23","author":"Arnott","year":"2004","journal-title":"Oncogene"},{"key":"10.1124\/jpet.111.179200_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-\u03b1 in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1124\/jpet.111.179200_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1124\/jpet.111.179200_bib6","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1101\/gad.1107303","article-title":"Mechanism of p38 MAP kinase activation in vivo","volume":"17","author":"Brancho","year":"2003","journal-title":"Genes Dev"},{"key":"10.1124\/jpet.111.179200_bib7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/MCB.20.5.1747-1758.2000","article-title":"Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation","volume":"20","author":"Chiariello","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.111.179200_bib8","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1073\/pnas.0409856102","article-title":"Phosphorylation at Thr-290 regulates Tpl2 binding to NF-\u03baB1\/p105 and Tpl2 activation and degradation by lipopolysaccharide","volume":"102","author":"Cho","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.111.179200_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1096\/fj.07-9078com","article-title":"Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity","volume":"22","author":"Choi","year":"2008","journal-title":"FASEB J"},{"key":"10.1124\/jpet.111.179200_bib10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/cvr\/cvp359","article-title":"Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells","volume":"85","author":"Choi","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.111.179200_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1476-4598-3-34","article-title":"Expression of the Tpl2\/Cot oncogene in human T-cell neoplasias","volume":"3","author":"Christoforidou","year":"2004","journal-title":"Mol Cancer"},{"key":"10.1124\/jpet.111.179200_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.bcp.2004.05.031","article-title":"Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention","volume":"68","author":"Chun","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.179200_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/gcc.20069","article-title":"Mutational activation of the MAP3K8 protooncogene in lung cancer","volume":"41","author":"Clark","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1124\/jpet.111.179200_bib14","doi-asserted-by":"crossref","first-page":"23748","DOI":"10.1074\/jbc.M412837200","article-title":"Tpl2\/Cot Signals Activate ERK, JNK, and NF-\u03baB in a cell-type and stimulus-specific manner","volume":"280","author":"Das","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.111.179200_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0024-3205(99)00120-4","article-title":"Flavonoids: old and new aspects of a class of natural therapeutic drugs","volume":"65","author":"Di Carlo","year":"1999","journal-title":"Life Sci"},{"key":"10.1124\/jpet.111.179200_bib16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1074\/jbc.M506790200","article-title":"The tyrosine kinase Syk regulates TPL2 activation signals","volume":"281","author":"Eliopoulos","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.111.179200_bib17","first-page":"2015","article-title":"Involvement of the Tpl-2\/cot oncogene in MMTV tumorigenesis","volume":"13","author":"Erny","year":"1996","journal-title":"Oncogene"},{"key":"10.1124\/jpet.111.179200_bib18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0006-2952(89)90309-2","article-title":"Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships","volume":"38","author":"Ferriola","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.179200_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tibs.2004.11.003","article-title":"Restraining PI3K: mTOR signalling goes back to the membrane","volume":"30","author":"Harrington","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/jpet.111.179200_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/1-4020-5688-5_4","article-title":"Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer","volume":"42","author":"Harris","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1124\/jpet.111.179200_bib21","doi-asserted-by":"crossref","first-page":"29672","DOI":"10.1074\/jbc.274.42.29672","article-title":"JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-\u03b1 but not by 12-O-tetradecanoylphorbol-13-acetate","volume":"274","author":"Huang","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.111.179200_bib22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.molcel.2006.07.028","article-title":"JNK2 is a positive regulator of the cJun transcription factor","volume":"23","author":"Jaeschke","year":"2006","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.111.179200_bib23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/154405910308200712","article-title":"Cot\/Tpl2 is essential for RANKL induction by lipid A in osteoblasts","volume":"82","author":"Kikuchi","year":"2003","journal-title":"J Dent Res"},{"key":"10.1124\/jpet.111.179200_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bcp.2008.10.027","article-title":"MKK4 is a novel target for the inhibition of tumor necrosis factor-\u03b1-induced vascular endothelial growth factor expression by myricetin","volume":"77","author":"Kim","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.179200_bib25","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.bcp.2010.01.008","article-title":"Cyanidin suppresses ultraviolet B-induced COX-2 expression in epidermal cells by targeting MKK4, MEK1, and Raf-1","volume":"79","author":"Kim","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.179200_bib26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1158\/1940-6207.CAPR-11-0032","article-title":"Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K","volume":"4","author":"Kim","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1124\/jpet.111.179200_bib27","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.192.12.1809","article-title":"Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice","volume":"192","author":"Knight","year":"2000","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.111.179200_bib28","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1084\/jem.20020281","article-title":"Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn\u2019s-like inflammatory bowel disease","volume":"196","author":"Kontoyiannis","year":"2002","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.111.179200_bib29","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/carcin\/bgp216","article-title":"Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase","volume":"30","author":"Kwon","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1124\/jpet.111.179200_bib30","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1158\/0008-5472.CAN-09-2316","article-title":"Tpl2 is a key mediator of arsenite-induced signal transduction","volume":"69","author":"Lee","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.111.179200_bib31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156800908786241050","article-title":"Luteolin, a flavonoid with potential for cancer prevention and therapy","volume":"8","author":"Lin","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1124\/jpet.111.179200_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0031-6997(24)01472-8","article-title":"The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer","volume":"52","author":"Middleton","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.111.179200_bib33","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/10552","article-title":"Mice deficient in tumor necrosis factor-\u03b1 are resistant to skin carcinogenesis","volume":"5","author":"Moore","year":"1999","journal-title":"Nat Med"},{"key":"10.1124\/jpet.111.179200_bib34","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1096\/fj.02-1038com","article-title":"The sphingosine kinase 1\/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-\u03b1","volume":"17","author":"Pettus","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/jpet.111.179200_bib35","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1055\/s-0028-1088314","article-title":"Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin","volume":"74","author":"Seelinger","year":"2008","journal-title":"Planta Med"},{"key":"10.1124\/jpet.111.179200_bib36","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1038\/sj.onc.1202891","article-title":"Overexpression of the Tpl-2\/Cot oncogene in human breast cancer","volume":"18","author":"Sourvinos","year":"1999","journal-title":"Oncogene"},{"key":"10.1124\/jpet.111.179200_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ccr.2006.05.002","article-title":"Kinase inhibitors: vice becomes virtue","volume":"9","author":"Vogt","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1124\/jpet.111.179200_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2011.02.004","article-title":"Tpl2 kinase signal transduction in inflammation and cancer","volume":"304","author":"Vougioukalaki","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1124\/jpet.111.179200_bib39","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1242\/jcs.03014","article-title":"NFAT3 is specifically required for TNF-\u03b1-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells","volume":"119","author":"Yan","year":"2006","journal-title":"J Cell Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524465464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524465464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.179200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:35:26Z","timestamp":1740018926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524465464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0022356524465464"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.179200","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Luteolin, a Novel Natural Inhibitor of Tumor Progression Locus 2 Serine\/Threonine Kinase, Inhibits Tumor Necrosis Factor-\u03b1-Induced Cyclooxygenase-2 Expression in JB6 Mouse Epidermis Cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.179200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}